Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Understanding How Antibodies Shape the Gut Microbiome

Understanding How Antibodies Shape the Gut Microbiome

What function does IgA carry out in the human immune system?

IgA is the most abundant class of immunoglobulin in the human body, with an estimated 80% of the total plasma cells in our body being IgA+.

Image Credit: Kateryna Kon / Shutterstock

Secretory IgA plays an important role as a frontline defense against pathogen invasion, and also to neutralize toxins and viruses.

Our previous studies extended this classic view by finding a role for IgA in the maintenance of commensal gut microbiota.

By using genetically modified mice, we showed that IgA-deficiency caused the expansion of certain members of commensal bacteria in the gut.

Thus, IgA is functioning not only to protect us from harmful pathogens but also to maintain the commensal gut microbiota in mice and humans.

Why is it important to study how antibodies affect the microbiome?

Gut microbiota are essential for many aspects of our health, and a disturbed microbiome can cause many diseases such as obesity, autoimmune diseases and colitis.

Understanding the mechanisms behind the maintenance of a “healthy” microbiota in the gut may lead to the development of new methods for the treatment or prophylaxis of diseases.

Bacteria in the gut microbiomeImage Credit: Anatomy Inside / Shutterstock

Our body consumes a lot of energy to generate large amounts of gut IgA, but very little is known about how the IgA interacts with commensal microbiota to induce beneficial effects for the host.

This system is very complex, considering the heterogeneity of the IgA repertoire and also the diversity of the gut microbiota both in composition and metabolic function.

To understand the mechanisms involved in the maintenance of gut homeostasis, we need to dissect this complexity, and the study of the interaction between IgA and the microbiome plays a major role in this.

Please describe your recent research.

We recently proved that IgA antibodies promote the growth of beneficial bacteria in the gut of a mouse model.

Firstly, in order to eliminate IgA-heterogeneity, we developed monoclonal IgA that recognizes OVA protein (7-6IgA). We found that the 7-6IgA was heavily glycosylated and bound on the surfaces of many bacteria independent of the antigen recognition site of the antibody.

Among the bacteria strains we tested, Bacteroides thetaiotaomicron (B.theta) – a prominent human gut microbiota – had the highest capacity to bind on the glycosylated 7-6IgA.

We next developed a mouse system in which 7-6IgA was the only gut IgA, and concomitantly colonized it with B. theta.

In the cecum of these mice, the gene expression profile of B. theta was significantly altered including the up-regulation of a functionally uncharacterized operon. We provisionally named this operon Mucus-Associated Functional Factor (MAFF).

Interestingly,  MAFF expression in vivo was induced only under the presence of diverse microbiota but not in mono-colonized mice, indicating that the function of this operon requires interaction with other bacterial members.

We observed that symbiotic bacteria belonging to phylum Firmicutes expanded under the function of the MAFF system and in the presence of IgA, showing that IgA and the MAFF system plays a critical role in symbiotic interactions between these bacterial members.

Finally, we applied chemically induced colitis to the B. theta colonized mice. Surprisingly, we found that the mice colonized with the MAFF-deletion mutant of B. theta quickly died from severe colitis, but those mice colonized with wild-type B. theta were protected from the colitis.

This was due to the metabolites produced by the expanded members of Firmicutes, which enhanced the regeneration of damaged epithelial cells. These studies showed that heavily glycosylated IgA induced the MAFF genes that promote symbiosis via inter-phylum interactions and maintain colonic homeostasis.

What impact could this research have on humans with conditions such as inflammatory bowel disease (IBS)?

In our experiments, we treated mice with antibiotics to colonize B. theta. We observed that there were clear batch effects among the experiments for chemical-sensitive and chemical-resistant groups after the antibiotics treatment.

Image Credit: Kateryna Kon / Shutterstock

The efficient elimination of the members of Firmicutes by antibiotics enhanced the severity of the colitis, and the effect of the MAFF system was clearly observed in chemical-sensitive batches of the experiments.

I think there would be heterogeneity between our research and ulcerative colitis patients. If so, we could categorize patients into subgroups according to the composition of their gut microbiome.

The IgA-MAFF axis could be an interesting target for IBD studies in some subgroups of ulcerative colitis patients because the MAFF system is present in human colonic mucus.

We are not yet ready for human studies, but I am hopeful that our research might have an impact on IBD studies and help in the development of new treatments and/or prophylaxis for ulcerative colitis.

What are the next steps for your research?

The next step is to identify the molecular target of the MAFF system and find out how its expression is regulated along with neighboring genetic elements.

We would also like to identify and isolate the members of Firmicutes who strongly interact with B. theta via the MAFF system, would be a powerful driving force to expand our current knowledge.

It would also be interesting to tackle more details of the heterogeneity of glycosylation status of gut IgA in mice and humans. We believe that answering these questions will help us to understand the detailed mechanisms of how gut microbiota maintain equilibrium in our body.

Where can readers find more information?

About Dr. Keiichiro Suzuki

Dr. Suzuki started his career in 1996 as a clinician in a department of gastroenterology, internal medicine.

After 5 years training as a gastroenterologist, he started his scientific career as a PhD student in the laboratory of Professor Tasuku Honjo, at Kyoto University. It was in Honjo’s lab that he met Sidonia Fagarasan, who had already published many interesting papers about IgA and mucosal immunity.

Dr. Suzuki obtained a Ph.D. of medicine at Kyoto University in 2004, and soon joined Sidonia’s lab at RIKEN Yokohama Institute as a postdoctoral fellow.

His next move was to the Innovation Center for Immunoregulation Technologies and Drugs, AK project, in Kyoto University as an Associate Professor, in 2011.

In 2016, he re-joined Sidonia’s lab in the RIKEN Yokohama Institute as a senior scientist.

Tagged with:

About author

Related Articles